rs786204781
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000308370.11(LTBP4):c.365del(p.Leu122ArgfsTer15) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,261,218 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )
Consequence
LTBP4
ENST00000308370.11 frameshift
ENST00000308370.11 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.46
Genes affected
LTBP4 (HGNC:6717): (latent transforming growth factor beta binding protein 4) The protein encoded by this gene binds transforming growth factor beta (TGFB) as it is secreted and targeted to the extracellular matrix. TGFB is biologically latent after secretion and insertion into the extracellular matrix, and sheds TGFB and other proteins upon activation. Defects in this gene may be a cause of cutis laxa and severe pulmonary, gastrointestinal, and urinary abnormalities. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-40600090-CT-C is Pathogenic according to our data. Variant chr19-40600090-CT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 189236.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP4 | NM_001042544.1 | c.365del | p.Leu122ArgfsTer15 | frameshift_variant | 4/33 | NP_001036009.1 | ||
LTBP4 | NM_003573.2 | c.254del | p.Leu85ArgfsTer15 | frameshift_variant | 4/33 | NP_003564.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP4 | ENST00000308370.11 | c.365del | p.Leu122ArgfsTer15 | frameshift_variant | 4/33 | 1 | ENSP00000311905 | A2 | ||
LTBP4 | ENST00000204005.13 | c.254del | p.Leu85ArgfsTer15 | frameshift_variant | 4/33 | 1 | ENSP00000204005 | A2 | ||
LTBP4 | ENST00000593738.1 | n.108del | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000919 AC: 14AN: 152266Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
152266
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000114 AC: 3AN: 26376Hom.: 0 AF XY: 0.0000823 AC XY: 1AN XY: 12148
GnomAD3 exomes
AF:
AC:
3
AN:
26376
Hom.:
AF XY:
AC XY:
1
AN XY:
12148
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000142 AC: 157AN: 1108952Hom.: 0 Cov.: 30 AF XY: 0.000150 AC XY: 79AN XY: 525768
GnomAD4 exome
AF:
AC:
157
AN:
1108952
Hom.:
Cov.:
30
AF XY:
AC XY:
79
AN XY:
525768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74390
GnomAD4 genome
AF:
AC:
14
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 20, 2024 | Has not been previously published as pathogenic or benign in association with a LTBP4-related disorder to our knowledge; Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25714468, 28654958, 30487145, 29565423, 29030401, 31256874, 31589614) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | This sequence change creates a premature translational stop signal (p.Leu85Argfs*15) in the LTBP4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LTBP4 are known to be pathogenic (PMID: 19836010, 22829427). This variant is present in population databases (rs747013505, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with LTBP4-related conditions. ClinVar contains an entry for this variant (Variation ID: 189236). For these reasons, this variant has been classified as Pathogenic. - |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 17, 2014 | The Leu85ArgfsX15 variant in LTBP4 has not been previously reported in individuals with autosomal recessive cutis laxa type I, but has been identified in 1/5840 of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This frameshift variant is predicted to alter the protein’s amino acid sequence beginning at position 85 and lead to a premature termination codon 15 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of LTBP4 function has previously been desribed in homozygous and compound heterozygous individuals with autosomal recessive cutis laxa type IC (Urban 2009, Callewaert 2013). In summary, this variant meets our criteria to be classified as pathogenic for autosomal recessive cutis laxa type IC (http://pcpgm.partners.org/LMM). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at